Funding news · Nov 13, 2026
Soombit.ai Raises ₩12B Series A Led by SV Investment
Soombit.ai Closes Series A Funding
Soombit.ai, a South Korean medical-imaging AI startup, has raised a Series A round of ₩12,000,000,000 (KRW). The funding date is recorded as November 13, 2026. SV Investment led the round, with participation from Altos Ventures, Kiwoom Investment, and IM Investment Partners.
Company Background
Founded in July 2024, Soombit.ai was established by the Kakao Brain team behind its chest X-ray AI business. The company is co-founded by CEO Woong Bae, who previously served as Kakao Brain's chief healthcare officer.
Product Focus: AIRead-CXR
The company's flagship product, AIRead-CXR, drafts preliminary chest X-ray reports directly inside radiologists' PACS workflow. In April 2026, it became Korea's first generative-AI-based digital medical device to receive MFDS Class III approval. Peer-reviewed studies have reported approximately 42% shorter reading times associated with the product.
Pipeline Expansion
Soombit.ai is extending its generative-AI report drafting capabilities to CT and MRI. Its AIRead-CT preliminary findings solution, aimed at brain, chest, and abdomen-pelvis scans, is planned for 2027. The company is also preparing US FDA and European CE approvals as part of its global commercialization strategy.
Funding Stage and Investor Profile
The Series A round brings together SV Investment as lead, alongside Altos Ventures, Kiwoom Investment, and IM Investment Partners. The capital follows the company's MFDS Class III approval and supports its expansion beyond chest X-ray into broader imaging modalities.
Acquisition Relevance
Soombit.ai combines a regulatory first in Korea's generative-AI medical device category with a measurable workflow benefit in radiology reading times. Its PACS-integrated approach positions the product close to daily clinical operations, while the planned CT and MRI expansion and pending US and European approvals point to a broader addressable market.
For acquirers in medical imaging, radiology workflow software, or clinical AI, Soombit.ai represents an early-stage asset with a cleared flagship device and a defined multi-modality roadmap.